tiprankstipranks
Polydex Pharmaceuticals Limited (POLXF)
OTHER OTC:POLXF
US Market

Polydex Pharmaceuticals (POLXF) Financial Statements

4 Followers

Polydex Pharmaceuticals Financial Overview

Polydex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Polydex Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 10Oct 09Jul 09Apr 09Jan 09
Income Statement-
Total Revenue$ 1.06M$ 1.15M$ 1.23M$ 1.03M$ 934.45K
Gross Profit$ -177.37K$ 77.53K$ -199.62K$ 207.73K$ -223.29K
EBIT$ -1.36M$ -202.63K$ -489.85K$ -40.59K$ -935.08K
EBITDA$ -1.25M$ -98.44K$ -397.46K$ 87.66K$ -819.55K
Net Income Common Stockholders$ -1.37M$ -216.44K$ -503.90K$ -53.73K$ -1.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 375.00K$ 492.75K$ 647.34K$ 423.51K$ 709.31K
Total Assets$ 5.75M$ 7.20M$ 7.37M$ 6.71M$ 6.33M
Total Debt$ 1.14M$ 1.13M$ 1.18M$ 928.41K$ 941.16K
Net Debt$ 765.09K$ 634.87K$ 530.60K$ 504.90K$ 231.84K
Total Liabilities$ 2.28M$ 2.42M$ 2.36M$ 1.80M$ 1.51M
Stockholders Equity$ 3.47M$ 4.78M$ 5.02M$ 4.91M$ 4.82M
Cash Flow-
Free Cash Flow$ -156.85K$ -103.77K$ -150.70K$ -246.73K$ 574.80K
Operating Cash Flow$ -140.63K$ -94.88K$ -128.41K$ -225.80K$ 551.03K
Investing Cash Flow$ 74.71K$ -11.84K$ -24.34K$ -23.04K$ 14.25K
Financing Cash Flow$ 7.90K$ -48.86K$ 211.12K$ -22.34K$ -188.47K
Currency in USD

Polydex Pharmaceuticals Earnings and Revenue History

Polydex Pharmaceuticals Debt to Assets

Polydex Pharmaceuticals Cash Flow

Polydex Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis